Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis

Neurology

Volumn 84, Issue 23, 2015, Pages 2377-2378

  Pfender, Nikolai ^a   Jelcic, Ilijas ^a   Linnebank, Michael ^a   Schwarz, Urs ^a   Martin, Roland ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BETA1A INTERFERON; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ADULT; ANTIVIRAL THERAPY; BRAIN ATROPHY; CASE REPORT; DISEASE SEVERITY; FEVER; FOLLOW UP; HERPES SIMPLEX ENCEPHALITIS; HERPESVIRIDAE; HUMAN; MALE; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUADRIPLEGIA; SCORING SYSTEM; SEIZURE; TREATMENT OUTCOME; UNCONSCIOUSNESS; VIRUS REACTIVATION; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHYSIOLOGY; VIRUS ACTIVATION;

ADULT; ENCEPHALITIS, HERPES SIMPLEX; FINGOLIMOD HYDROCHLORIDE; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROPYLENE GLYCOLS; SPHINGOSINE; VIRUS ACTIVATION;

EID: 84930711831     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001659     Document Type: Note

References (5)

1. Kappos L, Radue EW, O'Connor P, et al. A placebocontrolled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010;362:387-401.
2. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-415.
3. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
4. Calabresi PA, Radue EW, Goodin D, et al. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Neurol 2014;13:545-556.
5. Ricklin ME, Lorscheider J, Waschbisch A, et al. T-cell response against varicella-zoster virus in fingolimod-treated MS patients. Neurology 2013;81:174-181.